Dana-Farber Cancer Institute receives $20 million for metastatic breast cancer research
New England Council member, Dana-Farber Cancer Institute, received a $20 million grant from the Elaine and Eduardo Saverin Foundation to advance research and care for metastatic breast cancer, the most significant nonfederal award of its kind in the institute’s history.
The grant will expand clinical trials, AI-driven research, enhance data integration for more than 20,000 patients, and advance liquid diagnostics to detect early recurrence. “Metastatic breast cancer patients are often left on the margins of treatment conversations,” said Elaine Saverin. “Our goal is to help Dana-Farber make a meaningful impact on long-term outcomes for people living with late-stage disease.”
Dr. Sara Tolaney, Chief of Breast Oncology, expressed gratitude for the support, stating that the funding will help drive “more efficacious therapies” and support new technologies to improve patient outcomes.
The New England Council applauds Dana-Farber for its continued leadership in cutting-edge cancer research.
Read more in the Boston Globe.